Form 4: Pediatrix Executive Executes Internal Share Transfer

Mary Ann E. Moore, EVP and General Counsel of Pediatrix Medical Group, transferred 40,826 shares to a family trust.

Summary

• Mary Ann E. Moore, EVP, General Counsel, and Chief Administrative Officer of Pediatrix Medical Group, transferred 40,826 shares of common stock.
• The transaction occurred on May 11, 2026, at a price of $0, representing a transfer to a trust.
• Following the transaction, the reporting person holds 108,410 shares directly and 93,424 shares indirectly through a trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a change in the form of ownership rather than a divestment of equity.

Positives

• The transaction is a routine estate planning or internal transfer rather than a market sale, indicating no change in the executive's total economic interest.

Negatives

• None.

Risks

• None.

Future Outlook

Not applicable as this is a routine insider ownership disclosure.

Industry Context

StockSavvy.ai notes that internal share transfers to trusts are standard practice for corporate executives for estate planning purposes and do not typically signal a change in sentiment regarding company performance.

Comparison to Industry Standards

• This filing is consistent with standard SEC reporting requirements for executive officers under Section 16(a).

Related Party Transactions

• The reporting person transferred shares to a trust where she and her spouse serve as trustees and immediate family members are beneficiaries.

Stakeholder Impact

• No material impact on shareholders or company operations.

Key Dates

Keywords

Pediatrix Medical Group, MD, Form 4, Insider Trading, Share Transfer, Corporate Governance